Subscribe To

Price Alert Latest News Economic Calendar News

INVVY / Indivior target price hiked after company raises forecast for depot opioid addiction treatment

Indivior PLC (LSE:INDV) shares have been given a price target of 2,655p by Jefferies, implying over 40% upside, after the company raised sales guidance for its Sublocade slow-release treatment for opioid addiction. Following last month's capital markets day update for investors, analysts at the investment bank said Sublocade's potential is “significantly greater” than their prior expectations, while the secondary listing on NASDAQ planned for spring 2023 is seen providing further support to the shares. Read More

Demo Live Account See Partner Details

Content Topics

Indivior

Target

Price

Hiked

After

Company

Raises

Forecast

Opioid

Addiction

Treatment

Stock

INVVY

Posted: Jan 4 2023, 09:09

Author Name: Proactive Investors

INVVY News

By CNBC Television
June 12, 2023

Indivior CEO Mark Crossley on company mission: We help people suffering from addiction

Indivior CEO Mark Crossley joins 'Squawk Box' to discuss the company's mission, demand for substance abuse treatment, the opioid epidemic, and more.

By Reuters
June 2, 2023

Indivior reaches deal to resolve states' monopoly claim over opioid addiction drug

Indivior Plc said on Friday its unit had agreed to pay $102.5 million to settle a lawsuit by multiple state attorneys general accusing it of using ill

By PRNewsWire
April 25, 2023

Indivior To Participate In Bank of America Global Healthcare Conference 2023

SLOUGH, UK and RICHMOND, Va. , April 25, 2023 /PRNewswire/ -- Indivior PLC (LSE: INDV) today announced that it will participate in the following inves

By Seeking Alpha
January 18, 2023

Indivior: Healthy Defensive In A Difficult Economy

Drug addiction is on the rise but so are treatments for it, like those provided by Indivior for opioid usage. With growing revenues and exceptional ma

By Proactive Investors
January 4, 2023

Indivior target price hiked after company raises forecast for depot opioid addiction treatment

Indivior PLC (LSE:INDV) shares have been given a price target of 2,655p by Jefferies, implying over 40% upside, after the company raised sales guidanc

By Zacks Investment Research
June 6, 2022

Here's Why "Trend" Investors Would Love Betting on Indivior PLC (INVVY)

Indivior PLC (INVVY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.